Address
MedImmune Ventures Inc
One MedImmune Way
Gaithersburg, MD 20878
United States
Phone
Email
Website
Recent investment activity
KANDO id: 3030
Corporate information
Registration country
Funding rounds
Investment preferences
Investment activity status
Not investing
Selected investments
Displaying 1 - 25 of 30Company | Profile | Country | Date Sort ascending | Funding | ||
---|---|---|---|---|---|---|
Coferon Inc | Develops orally active drugs that act like small drug molecules, can permeate cell membranes, and once inside, can assemble into larger molecules | Series B | ||||
Catabasis Pharmaceuticals Inc | Series A | |||||
Ambit Biosciences Inc | A biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer. | Series D | ||||
Catabasis Pharmaceuticals Inc | Series A | |||||
Rib-X Pharmaceuticals Inc | N/A | |||||
Virdante Pharmaceuticals Inc | A privately held biopharmaceutical company focused on the development and commercialization of drugs for autoimmune and inflammatory disorders. | Series A | ||||
Arginetix Inc | Biopharmaceutical company dedicated to developing and commercializing novel therapeutic small molecule inhibitors of arginase. | Seed | ||||
BrainCells Inc | A neurogenesis-based drug discovery and development company targeting novel therapies for mood disorders and other central nervous system diseases. | Series B | ||||
VaxInnate Inc | A biotechnology company, engages in the development and production of vaccines for pandemic and seasonal influenza diseases. | Series C | ||||
Avidia Inc | Series B | |||||
Iomai Corp | Biopharmaceutical company focused on discovering and developing vaccines and immune system stimulants. | Series C | ||||
Inotek Pharmaceuticals Corp | Inotek Pharmaceuticals is a clinical-stage ophthalmic pharmaceutical company. | N/A | ||||
Corridor Pharmaceuticals Inc | N/A | |||||
Cellective Therapeutics Inc | N/A | |||||
Sequoia Pharmaceuticals Inc | Discovers and develops antiviral drugs that inhibits various forms of viruses and prevents the emergence of drug-resistant viruses. | N/A | ||||
LigoCyte Pharmaceuticals Inc | N/A | |||||
VaxInnate Corp | N/A | |||||
Vanda Pharmaceuticals Inc | Biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system disorders. | N/A | ||||
Tercica Inc | A biopharmaceutical company developing new therapeutics for endocrine system disorders. | N/A | ||||
Critical Therapeutics Inc | Discoverer, developer and commercialize novel therapies. | N/A | ||||
Elusys Therapeutics Inc | Develops antibody-based therapies to treat infectious diseases. | N/A | ||||
Applied Genetic Technologies Corp | A gene therapy company that designs, packages and delivers therapeutic genes to treat a variety of medical illnesses using the adeno-associates virus. | N/A | ||||
NeuProtect Pty Ltd | N/A | |||||
NKT Therapeutics Inc | N/A | |||||
Synovex Corp | N/A |
Pagination
Current team
Former team members
Employee | Company | Position | ||
---|---|---|---|---|
Edward Mathers | New Enterprise Associates Inc |